Current evidence of MTX efficacy in childhood chronic uveitis: a systematic review and meta-analysis

Gelijkaardige items

• PReS-FINAL-2347: Does switching anti-TNFΑ biologic agents an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach
  door: Simonini, G, et al.
  Gepubliceerd in: (2013)
• Non-anti TNF biologic modifier drugs in non-infectious refractory chronic uveitis: the current evidence from a systematic review
  door: Simonini, Gabriele, et al.
  Gepubliceerd in: (2014)
• Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
  door: Simonini, G, et al.
  Gepubliceerd in: (2011)
• Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
  door: Giani, TG, et al.
  Gepubliceerd in: (2008)
• PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
  door: Moretti, D, et al.
  Gepubliceerd in: (2013)